Lactobacillus brevis
Lactobacillus brevis is a heterofermentative lactic acid bacterium widely distributed in fermented food environments. Research has examined the strain's functional properties including antimicrobial activity, fermentation characteristics, and potential probiotic mechanisms. In vitro and animal studies have examined possible roles in fermentation and gut health, though human clinical evidence remains limited. The strain has been evaluated for safety in food production. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1,028 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 296 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
4899 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Inhibitory Effect of Levilactobacillus brevis on Salivary α‐Amylase: Evidence From In Vivo and In Vitro Study· Journal of Food Biochemistry · 2026
-
[2]
Source →Effects of GABA-enriched rice germ extract fermented by Lactobacillus brevis BJ20 on stress symptoms and related biomarkers in adults: a randomized, double-blind, placebo-controlled trial· Journal of Functional Foods · 2026
-
[3]
PMID 39875908 →Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults· Journal of Translational Medicine · 2025
-
[4]
PMID 40147282 →The Probiotic Effects of Lactobacillus brevis CD2 on Caries Related Variables of Dental Plaque Biofilm· International Dental Journal · 2025
-
[5]
PMID 38611334 →Supplementation with Lactiplantibacillus brevis GKEX Combined with Resistance Exercise Training Improves Muscle Mass, Strength Performance, and Body Fat Condition in Healthy Humans· Foods · 2024
-
[6]
PMID 38742994 →Supplementation with a Probiotic Formula Having β-Glucuronidase Activity Modulates Serum Estrogen Levels in Healthy Peri- and Postmenopausal Women· Journal of Medicinal Food · 2024
-
[7]
Source →Effect of Chocolate Containing Lactobacillus brevis NTT001 and Galactooligosaccharides on the Intestine: A Randomized, Placebo-Controlled, Double-Blind Crossover TrialLactobacillus brevis NTT001 およびガラクトオリゴ糖含有チョコレートの腸に対する影響―ランダム化プラセボ対照二重盲検クロスオーバー試験―· 薬理と治療 · 2021
-
[8]
Source →Effect of Chocolate Containing Lactobacillus brevis NTT001 and Galactooligosaccharides on the Intestine: A Randomized, Placebo-Controlled, Double-Blind Crossover TrialLactobacillus brevis NTT001およびガラクトオリゴ糖含有チョコレートの腸に対する影響-ランダム化プラセボ対照二重盲検クロスオーバー試験-· 薬理と治療 · 2021
-
[9]
PMID 33259688 →Lactobacillus brevis CD2 attenuates traumatic oral lesions induced by fixed orthodontic appliance: A randomized phase 2 trial· Orthodontics and Craniofacial Research · 2020
-
[10]
PMID 31593351 →Relation between cell‐bound exopolysaccharide production via plasmid‐encoded genes and rugose colony morphology in the probiotic Lactobacillus brevis KB290· Animal Science Journal · 2019